Last reviewed · How we verify

Zontivity — Competitive Intelligence Brief

Zontivity (VORAPAXAR) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Protease-activated Receptor-1 Antagonist. Area: Neuroscience.

marketed Protease-activated Receptor-1 Antagonist Proteinase-activated receptor 1 Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Zontivity (VORAPAXAR) — Key Therap.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Zontivity TARGET VORAPAXAR Key Therap marketed Protease-activated Receptor-1 Antagonist Proteinase-activated receptor 1 2014-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Protease-activated Receptor-1 Antagonist class)

  1. Key Therap · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Zontivity — Competitive Intelligence Brief. https://druglandscape.com/ci/vorapaxar. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: